Skip to main content

Treatment of CNS Tumors in Childhood Slows Academic Readiness

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 28, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Aug. 28, 2024 -- Treatment of central nervous system (CNS) tumors in early childhood is associated with slowed development of academic readiness, which predicts distal academic outcomes in reading and math, according to a study published online Aug. 20 in the Journal of the National Cancer Institute.

Melanie R. Somekh, Ph.D., from St. Jude Children's Research Hospital in Memphis, Tennessee, and colleagues examined academic readiness among 70 patients with newly diagnosed CNS tumors during early childhood in a prospective, longitudinal, multisite study. Patients were treated with chemotherapy, with or without photon or proton irradiation.

The researchers found that over time, mixed linear models revealed slowed development of academic readiness skills. At all time points, socioeconomic status was predictive of academic readiness. Compared with normative expectations, distal reading difficulties were proportionally greater, while there was no difference in math difficulties. Distal academic outcomes in reading and math were predicted by academic readiness.

"Findings regarding increased risk for slowed development of academic skills may inform caregiver education and provide meaningful insights for clinicians speaking with families about possible impacts of CNS tumor diagnosis and treatment on academic functioning amongst our youngest patients," the authors write. "Further, they highlight the need for close monitoring of academic readiness and the potential importance of implementing interventions targeting early academic skills in this population."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2024

Read this next

Annual Wasteful Spending on Lecanemab Estimated at $133 to $336 Million

FRIDAY, Oct. 18, 2024 -- Annual wasteful spending on discarded lecanemab is anticipated to range between $133 and $336 million, given current vial sizes, according to a research...

IDSA: EHR Order Set Reduces Antibiotic Duration in Children With AOM

THURSDAY, Oct. 17, 2024 -- Implementation of an electronic health record (EHR) order set increases compliance with the recommended duration of prescribed antibiotics for children...

In Utero Exposure to COVID-19 Not Tied to Later Neurodevelopmental Issues

THURSDAY, Oct. 17, 2024 -- Exposure to maternal COVID-19 is not associated with abnormal neurodevelopmental screening results through 24 months postpartum, according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.